Improved Identification and Antihypertension Pharmacotherapy in Cardiorenal Metabolic Syndrome: Focus on Racial/Ethnic Minorities, Olmesartan Medoxomil, and Combination Therapy
CardioRenal Medicine - Switzerland
doi 10.1159/000342968
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2012
Authors
Publisher
S. Karger AG